Thyroid cancer is the most common endocrine malignancy, being twice as prevalent in women, although men have a poorer prognosis. In Brazil, thyroid cancer is one of the main cancers among women, occupying the 5th position with 5.4% of the total. For each year of the 2020-2022 triennium, 11,950 new cases of thyroid cancer are estimated in the country in women, representing an estimated risk of 11.15/100,000 inhabitants. Signs and symptoms include a lump in the neck, swelling, pain, hoarseness, difficulty swallowing, respiratory problems and cough. Studies attribute the increase in the incidence of this thyroid carcinoma to the increase in iodine intake in the diet, as well as to genetic factors, since 20% of cases are related to the autosomal dominant gene. This study aims to identify the incidence and mortality rate of thyroid cancer in Brazil between 2012 and 2022. It also aims to verify the mortality rate by sex and age group and identify the region of the country with the highest mortality rate. This is an epidemiological, quantitative, and descriptive study. The research was carried out by collecting data related to Brazil from the INCA, SIM, and DATASUS databases. Throughout the period investigated, we observed a total of 8,679 deaths from thyroid cancer, of which 2,948 were in men, equivalent to 33.97%, and 5,731 were in women, with a percentage of 66.03%. Comparing the occurrence of deaths from thyroid cancer between men and women, it is observed that the mortality rate among women is approximately three times higher than that of the male population, throughout the period analyzed. The results found reinforce that mortality from thyroid cancer has been high in the last decade, affecting women more women than men. These results suggest that more investment is needed to minimize and, if possible, reverse the situation.
Read full abstract